Innergex Renewable Energy (INE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
23 Apr, 2026Executive summary
Q2 2024 generation reached 91% of long-term average, impacted by below-average wind, lower irradiance, and curtailments, but offset by strong hydro in Quebec and Chile and higher wind in the U.S. and Chile.
Asset availability remained high at 96%, reflecting strong operational discipline.
Executed minority sale of interests in an 826 MW Texas renewable portfolio, generating US$185.7 million in equity consideration and supporting deleveraging.
Major construction milestones include commissioning the 35 MW/175 MWh San Andrés BESS project in Chile and advancing Boswell and Hale Kuawehi projects.
Signed 30-year, CPI-indexed PPAs for 400 MW in Quebec and extended a 25-year PPA for Portneuf hydro, both with Hydro-Québec.
Financial highlights
Adjusted EBITDA Proportionate was $184 million, down 8% year-over-year due to generation mix and lower production from higher-priced assets.
Free Cash Flow per share for the trailing twelve months ended June 30, 2024, was $1.35, up from $0.57 a year ago.
Q2 2024 consolidated revenues and PTCs were $260 million, down 4% from Q2 2023.
Net loss for Q2 2024 was $23 million, compared to net earnings of $25 million in Q2 2023.
Payout ratio for trailing twelve months was 40%, down from 127% a year ago.
Outlook and guidance
Reaffirmed full-year 2024 guidance: Adjusted EBITDA Proportionate of $725–775 million and Free Cash Flow per share of $0.70–0.85.
CapEx budget for 2024 is fully funded; no material changes to full-year CapEx outlook.
Production expected at long-term averages with ~95% asset availability.
Expect more growth in 2025 as new projects come online.
Latest events from Innergex Renewable Energy
- 38% Texas asset stake sold for US$188M, removing final power hedge and reducing leverage.INE
Status Update3 Feb 2026 - Q3 2024 Adjusted EBITDA fell 3%, but Free Cash Flow and guidance remain strong.INE
Q3 202415 Jan 2026 - 2024 results exceeded guidance, with strong growth, new awards, and higher 2025 targets set.INE
Q4 202416 Dec 2025 - Revenue up 12% and net loss narrowed as CDPQ acquisition advances toward Q4 close.INE
Q1 20256 Jun 2025